U.S. animal owners and veterinary practices should check whether their compounded medicines are included in Wedgewood Pharmacy’s recall over potential potency problems. The company’s October 21 notice covers certain products still within expiry that were shipped nationwide from February 18 through October 6, 2026.
Tonight We Ride, LLC is recalling all lots of Ultimate Forza Male Supplement after testing found undeclared sildenafil, tadalafil and dapoxetine. The October 24 announcement says the affected products were distributed through certain independently operated GNC franchises in the United States, rather than GNC corporate stores, from 2017 through October 1, 2026.
Natural Grocers customers should check the pack-date code on 2-pound bags of the chain’s organic mung beans after a recall prompted by complaints about sharp glass fragments. The October 22 company notice covers UPC 000080112600 and five specific codes, with affected lots potentially shipped to stores in 22 states.
Shoppers with a sesame allergy should check WinCo Foods hoagie rolls against a recall covering stores in seven western states. The company’s October 22 notice identifies 16-ounce bags with UPC 2-70552-00649-2 and best-by dates from September 10 through November 3, 2026, after sesame flour was omitted from the ingredient list and allergen statement.
The FDA stops mailing mammography-facility certificates and certification letters on October 22, shifting delivery to its MQSA Facility Portal. The change puts downloading and printing in the facility’s hands while retaining the requirement to display a printed certificate on-site. It does not apply to certificates issued by FDA-approved state certifying agencies.
U.S. Medicare beneficiaries can review and change their health or drug coverage during the annual enrollment window now underway, which runs from October 15 through December 7. Medicare’s official guidance says changes made during this period take effect January 1, 2027, provided the plan receives the enrollment request by December 7.
FDA’s Oncology Center of Excellence made patients’ experiences beyond the immediate treatment period a central question in the agenda for its October 15, 2026 virtual cancer-trials workshop. The U.S. event’s published program addresses whether existing measures capture what matters to people living longer with cancer.
U.S. consumers and food businesses have until December 9, 2026, to comment on FDA’s proposed changes to oversight of food-substance uses claimed to be generally recognized as safe. The agency scheduled an October 15 webinar to explain the proposal, which remains a proposed rule rather than a final requirement.
Find the subjects that matter to you.